electroCore market cap ECOR
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $63.6M
- Highest close in our data
- $514.5M
- Sep 2018
electroCore is worth $63.6M at the close on Oct 23, 2026, at $7.05 a share.
That is up 68% over the last year and down 3% over five years.
Its highest close in our data was $514.5M in Sep 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $63.6M | $36.4M | $105.3M | +61% |
| 2025 | $39.6M | $34.5M | $115.8M | −63% |
| 2024 | $107.9M | $33.9M | $107.9M | +202% |
| 2023 | $35.7M | $15.6M | $37M | +95% |
| 2022 | $18.3M | $17.7M | $53.8M | −56% |
| 2021 | $41.2M | $41.2M | $130M | −42% |
| 2020 | $70.9M | $11.9M | $101.1M | +83% |
| 2019 | $38.7M | $36.3M | $264.2M | −77% |
| 2018 | $167.6M | $124M | $514.5M | n/a |
Against its peers
Companies in Healthcare nearest electroCore's size, closest first, today.
| Company | Market cap |
|---|---|
| ECORelectroCore | $63.6M |
| SPROSpero Therapeutics | $64.6M |
| APTAlpha Pro Tech | $56.7M |
| LFVNLifevantage | $73.4M |
| ATNMActinium Pharmaceuticals | $47.8M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| NEPHNephros | $38.3M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $83.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on electroCore
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.